Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

InMed Pharmaceuticals Inc. - Common Shares (NQ:INM)

2.716 +0.047 (+1.77%)
Streaming Delayed Price Updated: 3:56 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,162
Open 2.640
Bid (Size) 2.590 (1)
Ask (Size) 2.750 (3)
Prev. Close 2.669
Today's Range 2.560 - 2.720
52wk Range 1.720 - 15.70
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Nano-Cap InMed Ignites Retail Frenzy As Stock Soars After Alzheimer's Drug Trial Shows Promise
The positive trial results propelled InMed into the top 25 trending stocks on Stocktwits, with a flood of bullish comments on the platform. 
Via Stocktwits

Performance

YTD
-43.4%
-43.4%
1 Month
-5.7%
-5.7%
3 Month
-39.6%
-39.6%
6 Month
-45.2%
-45.2%
1 Year
-54.7%
-54.7%

More News

Read More
Crude Oil Down 2%; D.R. Horton Earnings Top Views
Via Benzinga
Exposures Fossil Fuels
Why InMed Pharmaceuticals (INM) Stock Is Skyrocketing
Via Benzinga
Dow Jumps 200 Points; 3M Posts Upbeat Q4 Results
Via Benzinga
Topics Stocks
Exposures US Equities
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Fiscal 2024 Financial Results, Provides Business Update
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
CBDNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) BayMedica Poised as Rare Cannabinoids Drive Market Growth
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-901: A Promising New Candidate for Alzheimer’s Therapy
Via Investor Brand Network
InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer’s Drug INM-901
Via Investor Brand Network
Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Three U.S. Patent Issuances
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Crude Oil Falls; Palo Alto Networks Shares Jump After Q4 Earnings
Via Benzinga
Exposures Fossil Fuels
Nasdaq Moves Lower; Medtronic Posts Upbeat Earnings
Via Benzinga
BioMedNewsBreaks — InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Exciting INM-901 Data Providing ‘Attractive Therapeutic Approach’ in Alzheimer’s Treatment
Via Investor Brand Network
InMed Pharmaceuticals Advances Oral Candidate For Alzheimer's Disease, Stock Surges On Tuesday
Via Benzinga
US Stocks Mixed; Lowe's Cuts FY24 Forecast
Via Benzinga
BioMedNewsBreaks — InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089 Showing Great Promise in Treating AMD
Via Investor Brand Network
InMed Pharmaceuticals Inc. (NASDAQ: INM) Subsidiary BayMedica Releases Market Report for 2023 on “Minor Cannabinoids”
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
InMed Pharmaceuticals Inc. (NASDAQ: INM) Subsidiary BayMedica Releases Market Report for 2023 on “Minor Cannabinoids”
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Long-Term Study Results Confirm Positive Results of Developing Treatment for AD
Via Investor Brand Network
InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089, a Promising Treatment for Age-Related Macular Degeneration
Via Investor Brand Network
InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089, a Promising Treatment for Age-Related Macular Degeneration
Via CannabisNewsWire
The Rising Importance Of Minor Cannabinoids In The Growing Edible Market
Via News Direct
Topics Cannabis
Exposures Cannabis
BioMedNewsBreaks — InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Significant Improvements from INM-089 in AMD, Validates INM-901 as Potential AD Treatment
Via Investor Brand Network

Frequently Asked Questions

Is InMed Pharmaceuticals Inc. - Common Shares publicly traded?
Yes, InMed Pharmaceuticals Inc. - Common Shares is publicly traded.
What exchange does InMed Pharmaceuticals Inc. - Common Shares trade on?
InMed Pharmaceuticals Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for InMed Pharmaceuticals Inc. - Common Shares?
The ticker symbol for InMed Pharmaceuticals Inc. - Common Shares is INM on the Nasdaq Stock Market
What is the current price of InMed Pharmaceuticals Inc. - Common Shares?
The current price of InMed Pharmaceuticals Inc. - Common Shares is 2.716
When was InMed Pharmaceuticals Inc. - Common Shares last traded?
The last trade of InMed Pharmaceuticals Inc. - Common Shares was at 04/17/25 03:56 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.